For the Inventor, By the Inventor

Enter assignee name

Menlo Park, CA, United States of America

Sequus Pharmaceuticals, Inc.

USPTO Granted Patents = 15

Trademarks = 1

Forward Citations = 1,156

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Francis J Martin (11 out of 55 patents)

Samuel Zalipsky (9 out of 43 patents)

Martin C Woodle (4 out of 13 patents)

4. Shi Kun Huang (3 out of 19 patents)

5. Theresa M Allen (3 out of 16 patents)

6. Yechezkel Barenholz (2 out of 60 patents)

7. Bei Jin (2 out of 3 patents)

8. Edwin Kiyoshi Oto (2 out of 2 patents)

9. Mohammad Hassanipour (2 out of 2 patents)

10. Karen Reis (2 out of 2 patents)

11. Robert M Abra (2 out of 12 patents)

12. Paul S Uster (2 out of 6 patents)

13. Danilo D Lasic (1 out of 5 patents)

14. Irma Ajm Bakker-Woudenberg (1 out of 1 patent)

15. Josh Gittelman (1 out of 1 patent)

15 patents: Sort by Forward Citations

1. 6326353 - Enhanced circulation effector composition and method (2001-12-04),

2. 6316024 - Therapeutic liposome composition and method of preparation (2001-11-13),

3. 6224903 - Polymer-lipid conjugate for fusion of target membranes (2001-05-01),

4. 6180134 - Enhanced ciruclation effector composition and method (2001-01-30),

5. 6133026 - Condensed plasmid-liposome complex for transfection (2000-10-17),

6. 6126966 - Liposomes containing a cisplatin compound (2000-10-03),

7. 6056973 - Therapeutic liposome composition and method of preparation (2000-05-02),

8. 6043094 - Therapeutic liposome composition and method (2000-03-28),

9. 5972379 - Liposome composition and method for administering a quinolone (1999-10-26),

10. 5945122 - Liposomes containing a cisplatin compound (1999-08-31),

11. 5891468 - Fusogenic liposome compositions and method (1999-04-06),

12. 5851818 - Condensed plasmid-liposome complex for transfection (1998-12-22),

13. 5843473 - Method of treatment of infected tissues (1998-12-01),

14. 5631018 - Lipid-polymer conjugates and liposomes (1997-05-20),

15. 5527528 - Solid-tumor treatment method (1996-06-18),

Sequus Pharmaceuticals, Inc. is a biopharmaceutical company based in Menlo Park, California, specializing in the development of innovative drug delivery systems. The company focuses on creating advanced formulations and technologies to enhance the therapeutic efficacy of existing drugs, particularly in oncology and other critical therapeutic areas. By leveraging proprietary delivery mechanisms, Sequus aims to improve patient outcomes and expand the potential of established medications, contributing to the evolving landscape of pharmaceutical therapies.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

15 Patents

#94 in Menlo Park, CA

#5,022 in California

#21,034 in US

#39,881 in the World

Menlo Park, CA, United States of America

Sequus Pharmaceuticals, Inc.

Forward Citations = 1,156

16 inventors:

Francis J Martin (11 out of 55 patents)

Samuel Zalipsky (9 out of 43 patents)

Martin C Woodle (4 out of 13 patents)

4. Shi Kun Huang (3 out of 19 patents)

5. Theresa M Allen (3 out of 16 patents)

Please report any incorrect information to [email protected]

Loading…